NanoVibronix, Inc. (NAOV)

NASDAQ: NAOV · Real-Time Price · USD
0.384
-0.001 (-0.31%)
At close: Feb 21, 2025, 4:00 PM
0.376
-0.008 (-2.03%)
After-hours: Feb 21, 2025, 6:52 PM EST
-0.31%
Market Cap 2.36M
Revenue (ttm) 3.29M
Net Income (ttm) -3.09M
Shares Out 6.14M
EPS (ttm) -1.22
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 218,836
Open 0.380
Previous Close 0.385
Day's Range 0.370 - 0.395
52-Week Range 0.362 - 1.270
Beta 1.63
Analysts n/a
Price Target n/a
Earnings Date Apr 7, 2025

About NAOV

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat p... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 16
Stock Exchange NASDAQ
Ticker Symbol NAOV
Full Company Profile

Financial Performance

In 2023, NanoVibronix's revenue was $2.28 million, an increase of 203.59% compared to the previous year's $752,000. Losses were -$3.71 million, -31.88% less than in 2022.

Financial Statements

News

NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announced the completion of the...

7 days ago - Business Wire

NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Port...

6 weeks ago - Business Wire

NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Port...

6 weeks ago - Business Wire

NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Por...

2 months ago - Business Wire

NanoVibronix Provides Business Update

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portab...

3 months ago - Business Wire

NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (“SAW”) P...

4 months ago - Business Wire

NanoVibronix Signs Letter of Intent with Potential New Distributor

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Por...

5 months ago - Business Wire

NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic ...

6 months ago - Business Wire

NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic ...

9 months ago - Business Wire

NanoVibronix Issues Letter to Stockholders

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Th...

10 months ago - Business Wire

NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield

TYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix,” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acousti...

10 months ago - Business Wire

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs' FSS Contract Award

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix,” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acous...

10 months ago - Business Wire

NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024

1x1 Meetings on Thursday, May 2, 2024 ELMSFORD, NY / ACCESSWIRE / April 24, 2024 / NanoVibronix, Inc. (Nasdaq:NAOV) ("NanoVibronix" or the "Company"), a medical device company that produces the UroShi...

10 months ago - Accesswire

NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoust...

11 months ago - Business Wire

NanoVibronix Featured in Your Bladder Health Magazine

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic...

1 year ago - Business Wire

NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic ...

1 year ago - Business Wire

NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic ...

1 year ago - Business Wire

NanoVibronix Regains Nasdaq Compliance

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV) (the “Company”), a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrason...

1 year ago - Business Wire

NanoVibronix Issues Letter to Shareholders

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic...

1 year ago - Business Wire

NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic ...

1 year ago - Business Wire

NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic ...

1 year ago - Business Wire

NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic...

1 year ago - Business Wire

NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic...

1 year ago - Business Wire

NanoVibronix Cites Positive Results from Independent Testing of UroShield

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic ...

1 year ago - Business Wire

NanoVibronix Responds to CMS' Determination for PainShield

ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic...

1 year ago - Business Wire